Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.

Autor: Khazan N; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Quarato ER; Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA., Singh NA; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Snyder CWA; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Moore T; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Miller JP; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA., Yasui M; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA., Teramoto Y; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA., Goto T; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA., Reshi S; School of Mathematical and Natural Sciences, University of Arizona College of Medicine, Phoenix, AZ 85004, USA., Hong J; School of Mathematical and Natural Sciences, University of Arizona College of Medicine, Phoenix, AZ 85004, USA., Zhang N; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Pandey D; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Srivastava P; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Morell A; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Kawano H; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Kawano Y; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Conley T; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Sahasrabudhe DM; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Yano N; Division of Surgical Research, Rhode Island Hospital, Brown University, Providence, RI 02912, USA., Miyamoto H; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA., Aljitawi O; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Liesveld J; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Becker MW; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Calvi LM; Department of Medicine, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Zhovmer AS; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Tabdanov ED; CytoMechanobiology Laboratory, Department of Pharmacology, Penn State College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA., Dokholyan NV; Department of Pharmacology, Department of Biochemistry & Molecular Biology, Center for Translational Systems Research, Penn State College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA., Linehan DC; Division of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA., Hansen JN; Department of Psychological and Brain Sciences, Colgate University, Hamilton, NY 13346, USA., Gerber SA; Division of Surgery and Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.; Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA., Sharon A; Birla Institute of Technology, Ranchi 835215, India., Khera MK; Presude Lifesciences, Delhi 110075, India., Jurutka PW; School of Mathematical and Natural Sciences, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.; School of Mathematical and Natural Sciences, Arizona State University, Health Futures Center, Phoenix, AZ 85054, USA., Rochel N; Institute of Genetics and of Molecular and Cellular Biology, 67400 Illkirch-Graffenstaden, France., Kim KK; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Rowswell-Turner RB; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Singh RK; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA., Moore RG; Wilmot Cancer Institute and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14642, USA.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jun 30; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 30.

Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II.

Autor: Khera MK; Department of Medicinal Chemistry, New Drug Discovery Research, Ranbaxy Laboratories Limited, R&D III, Plot No. 20, Sector-18, Udyog Vihar Industrial Area, Gurgaon 122001, India. manoj.khera.c4@dsin.co.in, Cliffe IA, Prakash O

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Sep 15; Vol. 21 (18), pp. 5266-9. Date of Electronic Publication: 2011 Jul 19.

Synthesis of conformationally constrained analogues of linezolid: structure-activity relationship (SAR) studies on selected novel tricyclic oxazolidinones.

Autor: Selvakumar N; Anti-Infectives Discovery Group, Dr. Reddy's Research Foundation, Bollaram Road, Miyapur, Hyderabad 500 050, India., Srinivas D, Khera MK, Kumar MS, Mamidi RN, Sarnaik H, Charavaryamath C, Rao BS, Raheem MA, Das J, Iqbal J, Rajagopalan R

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2002 Aug 29; Vol. 45 (18), pp. 3953-62.